Matches in Wikidata for { <http://www.wikidata.org/entity/Q56516321> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q56516321 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56516321 description "wetenschappelijk artikel" @default.
- Q56516321 description "наукова стаття, опублікована в серпні 2018" @default.
- Q56516321 name "Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients re" @default.
- Q56516321 name "Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients re" @default.
- Q56516321 type Item @default.
- Q56516321 label "Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients re" @default.
- Q56516321 label "Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients re" @default.
- Q56516321 prefLabel "Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients re" @default.
- Q56516321 prefLabel "Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients re" @default.
- Q56516321 P1433 Q56516321-8028D88A-9EE6-43BE-AA9C-081A79BD11F6 @default.
- Q56516321 P1476 Q56516321-51302A6D-3689-4E25-AD3D-35A7E09AA377 @default.
- Q56516321 P2093 Q56516321-00AA649F-4607-45D1-B578-867F12939504 @default.
- Q56516321 P2093 Q56516321-0B68AE3A-2746-4F83-BE1E-297E2EF3FD01 @default.
- Q56516321 P2093 Q56516321-212DC59A-DBD8-4F61-B0AE-CC4B48B6A241 @default.
- Q56516321 P2093 Q56516321-4066E812-A30C-4BA0-9C9D-36A30242ACEE @default.
- Q56516321 P2093 Q56516321-4887A534-FF59-4F84-8C92-0BB9CF12A582 @default.
- Q56516321 P2093 Q56516321-4EF4350C-2CDD-4174-80D7-FC229A457F67 @default.
- Q56516321 P2093 Q56516321-5C53000A-5E47-4986-BA9B-C84C6AD9C704 @default.
- Q56516321 P2093 Q56516321-6E646551-F4BF-4B7C-9566-6A889D5CCC2C @default.
- Q56516321 P2093 Q56516321-76958CFF-1AD7-482C-902D-1C4B5F4BE667 @default.
- Q56516321 P2093 Q56516321-BC02F326-EC0D-4A86-9D39-66E302FF618C @default.
- Q56516321 P2093 Q56516321-E2210632-3C64-4A63-8660-BC0E43F9FD4B @default.
- Q56516321 P31 Q56516321-DB2C5895-9757-467B-9AEC-97F76F163B56 @default.
- Q56516321 P356 Q56516321-1645593B-7D39-49BB-996A-9F2B70E37FC3 @default.
- Q56516321 P407 Q56516321-A281D9B8-F13A-4227-85BB-0FA0E01431B2 @default.
- Q56516321 P577 Q56516321-DE56F050-1586-4999-984A-179B4C342182 @default.
- Q56516321 P698 Q56516321-E383ACA5-4CC4-44F8-8C6B-75A8D808503B @default.
- Q56516321 P921 Q56516321-489C4339-BC85-44EB-9445-C1EC8735C823 @default.
- Q56516321 P921 Q56516321-C988E0EF-9572-485C-91E7-F444B5991D18 @default.
- Q56516321 P921 Q56516321-D80CB461-F719-4562-8FF1-DE0232418AF1 @default.
- Q56516321 P356 HYY114 @default.
- Q56516321 P698 30124989 @default.
- Q56516321 P1433 Q2231629 @default.
- Q56516321 P1476 "Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients re" @default.
- Q56516321 P2093 "Haruhiko Fukuda" @default.
- Q56516321 P2093 "Hironobu Hashimoto" @default.
- Q56516321 P2093 "Masakazu Abe" @default.
- Q56516321 P2093 "Mikio Mori" @default.
- Q56516321 P2093 "Noboru Yamamoto" @default.
- Q56516321 P2093 "Sadamoto Zenda" @default.
- Q56516321 P2093 "Satoru Iwasa" @default.
- Q56516321 P2093 "Takako Yanai" @default.
- Q56516321 P2093 "Takuhiro Yamaguchi" @default.
- Q56516321 P2093 "Yosuke Uchitomi" @default.
- Q56516321 P2093 "Yuichiro Ohe" @default.
- Q56516321 P31 Q13442814 @default.
- Q56516321 P356 "10.1093/JJCO/HYY114" @default.
- Q56516321 P407 Q1860 @default.
- Q56516321 P577 "2018-08-14T00:00:00Z" @default.
- Q56516321 P698 "30124989" @default.
- Q56516321 P921 Q111908491 @default.
- Q56516321 P921 Q269829 @default.
- Q56516321 P921 Q974135 @default.